Skip to main content

Table 1 Characteristics of study participants

From: Association between metformin use and disease progression in obese people with knee osteoarthritis: data from the Osteoarthritis Initiative—a prospective cohort study

 

Metformin users

N = 56

Non-users

N = 762

p*

Baseline data

 Age, years

62.3 (7.7)

61.7 (8.5)

0.64

 Female, n (%)

41 (73.2)

492 (64.6)

0.19

 Body mass index, kg/m2

34.9 (3.8)

33.9 (3.1)

0.02

 WOMAC pain score

5.8 (4.4)

4.3 (4.1)

0.01

Kellgren-Lawrence grade, n (%)

  

0.93

 2

28 (50.0)

386 (50.7)

 

 3

21 (37.5)

293 (38.4)

 

 4

7 (12.5)

83 (10.9)

 

Longitudinal data over 4–6 years

 Self-reported diabetes over 4 years, n (%)

55 (98.2)

68 (8.9)

< 0.001

 Change in weight over 4 years, kg (n = 674)

− 1.4 (8.4)

− 0.6 (6.6)

0.45

Annual % loss in cartilage volume over 4 years (n = 540)

 Medial compartment

1.15 (1.29)

1.53 (1.63)

0.19

 Lateral compartment

1.31 (1.12)

1.20 (1.40)

0.65

Total knee replacement over 6 years, n (%)

3 (5.4)

88 (11.6)

0.16

  1. Data presented as mean (standard deviation) or no (%)
  2. *For the difference between metformin users and non-users using independent samples t test or chi-square test